MEDIBANK PRIVATE LIMITED — Director's Dealing 2021

May 16, 2021

==> picture [596 x 114] intentionally omitted <==

17 May 2021

Final Director’s Interest Notice – Craig Drummond

In accordance with the Listing Rules, Medibank attaches an Appendix 3Z – Final Director’s Interest Notice for Craig Drummond for release to the market.

Craig Drummond ceased to be the CEO and Managing Director of Medibank on 17 May 2021.

Mr Drummond will continue to be employed by Medibank until 30 June 2021; any forfeiture of performance rights in accordance with Medibank’s Performance Rights Plan will occur after that date.

This document has been authorised for release by Mei Ramsay, Company Secretary.

Medibank Private Limited ABN 47 080 890 259 GPO Box 9999 Telephone 132 331 medibank.com.au

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

documents given toIntroduced 30/9/2001.	ASX become ASX’s property and may be made public.
Name of entity	Medibank Private Limited
ABN	47 080 890 259

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Craig Drummond
Date of last notice	17 May 2021
Date that director ceased to be director	17 May 2021

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

2,217,668 performance rights pursuant to the Medibank Private Limited Performance Rights Plan ( Performance Rights ), being:

• 790,720 Performance Rights granted under the FY19 Long Term Incentive ( LTI );

• 665,028 Performance Rights granted under the FY20 LTI; and

• 761,920 Performance Rights granted under the FY21 LTI.

1,313,839 Ordinary Shares.

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Z Page 1

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Number & class of securities Note: Provide details of the circumstances giving rise to the relevant interest 50,000 Ordinary Shares. Invia Custodian Pty Ltd on behalf of B & C Drummond

Part 3 – Director’s interests in contracts

==> picture [406 x 161] intentionally omitted <==

----- Start of picture text ----- Detail of contractNature of interestName of registered holder(if issued securities)No. and class of securities towhich interest relates----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002